O'Brien Greene & Co. Inc Eli Lilly & CO Transaction History
O'Brien Greene & Co. Inc
- $305 Million
- Q3 2024
A detailed history of O'Brien Greene & Co. Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, O'Brien Greene & Co. Inc holds 904 shares of LLY stock, worth $710,010. This represents 0.26% of its overall portfolio holdings.
Number of Shares
904
Previous 955
5.34%
Holding current value
$710,010
Previous $864,000
7.41%
% of portfolio
0.26%
Previous 0.29%
Shares
11 transactions
Others Institutions Holding LLY
# of Institutions
4,033Shares Held
737MCall Options Held
8.26MPut Options Held
10.5M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$76.1 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.8MShares$57.9 Billion1.2% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$51.7 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$40.3 Billion29.2% of portfolio
-
State Street Corp Boston, MA33.9MShares$26.6 Billion1.24% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $746B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...